Charles Dunn

Investment Analyst

At SV Health Investors:

Charles joined SV in London as Management Accountant before additionally taking on the role of Investment Analyst, in which he supports SV’s company creation effort – in particular he has worked with TRex and Ervaxx. Charles provides support to the deal team throughout the investment process, as well as providing operational and finance support to early stage portfolio companies.

Prior experience:
Charles qualified as an ACA after 3 years at Deloitte, with a focus on Life Sciences clients including SV portfolio companies.

Academic Credentials:
MSci Human Genetics, University College London; specialization in the genetics of neurodegenerative disease and cancer biology. Chartered accountant (ACA).

Team
Investment Team

Sector
Biotechnology

Sector Administrator
Sarah Wright (Rachel Jones)

Office
London